CMS said April 4 it will not move forward with a Biden-era proposal to allow Medicare coverage of GLP-1 drugs when prescribed ...

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the ... including GLP-1 benefits and coverage. Cigna CEO David Cordani speaks at The ...

GLP-1 drugs such as semaglutide ... Their popularity as a tool for weight loss skyrocketed after the US Food and Drug Administration (FDA) approved semaglutide for weight management in 2021.

Roundhill GLP-1 & Weight Loss ETF stock opened at $23.16 on Wednesday. Roundhill GLP-1 & Weight Loss ETF has a 52 week low of $23.09 and a 52 week high of $29.21. The firm has a market cap of $37. ...